It has been demonstrated that transferrin receptor (TfR) levels and TfR-mediated internalization mechanisms at the blood–brain barrier (BBB) are preserved in the presence of the AD neuropathology, including Aβ and TAU pathologies [226]. The gene discussed is TFRC; the disease is Alzheimer disease.